Vladimir M Shkolnikov
Overview
Explore the profile of Vladimir M Shkolnikov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
1550
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nikoloski Z, Somanathan A, Shkolnikov V, Sheiman I, Mossialos E
BMJ Public Health
. 2025 Feb;
2(1):e000173.
PMID: 40018127
Introduction: Unmet need for healthcare is a proxy indicator used to assess the performance of healthcare systems throughout the world. While the Russian Federation is committed to improving healthcare for...
2.
Shkolnikov V, Jdanov D, Majeed A, Islam N
BMJ Glob Health
. 2024 Apr;
9(4).
PMID: 38637122
No abstract available.
3.
Kolobova M, Jdanov D, Jasilionis D, Shkolnikov V, Rau R
Eur J Public Health
. 2023 Jul;
33(5):930-936.
PMID: 37470231
Background: Intra-annual excess mortality is the most reliable measure of losses of lives due to short-term risk factors. The objectives of our study are (i) to estimate excess mortality across...
4.
Nikoloski Z, Shkolnikov V, Mossialos E
Lancet Reg Health Eur
. 2023 May;
29:100631.
PMID: 37180281
Background: Avoidable mortality, including both treatable and preventable deaths, is frequently used as an indicator of health system performance. Whilst the term treatable mortality refers to deaths that might be...
5.
Nepomuceno M, Klimkin I, Jdanov D, Alustiza-Galarza A, Shkolnikov V
Popul Dev Rev
. 2022 May;
48(2):279-302.
PMID: 35600716
Estimating excess mortality is challenging. The metric depends on the expected mortality level, which can differ based on given choices, such as the method and the time series length used...
6.
Shkolnikov V, Klimkin I, Mckee M, Jdanov D, Alustiza-Galarza A, Nemeth L, et al.
SSM Popul Health
. 2022 May;
18:101118.
PMID: 35573866
Excess mortality has been used to measure the impact of COVID-19 over time and across countries. But what baseline should be chosen? We propose two novel approaches: an alternative retrospective...
7.
Trias-Llimos S, Cook S, Eggen A, Kudryavtsev A, Malyutina S, Shkolnikov V, et al.
Int J Equity Health
. 2022 Apr;
21(1):51.
PMID: 35428237
Background: Socioeconomic inequalities in cardiovascular (CVD) health outcomes are well documented. While Russia has one of the highest levels of CVD mortality in the world, the literature on contemporary socio-economic...
8.
Krieger E, Kudryavtsev A, Sharashova E, Postoev V, Belova N, Shagrov L, et al.
Emerg Infect Dis
. 2022 Jan;
28(2):463-465.
PMID: 35076366
Population-based data on coronavirus disease in Russia and on the immunogenicity of the Sputnik V vaccine are sparse. In a survey of 1,080 residents of Arkhangelsk 40-75 years of age,...
9.
Timonin S, Klimkin I, Shkolnikov V, Andreev E, Mckee M, Leon D
SSM Popul Health
. 2022 Jan;
17:101006.
PMID: 35005187
Background: Russia has been portrayed in media as having one of the highest death tolls due to the COVID-19 pandemic in the world. However, the precise scale of excess mortality...
10.
Timonin S, Shkolnikov V, Andreev E, Magnus P, Leon D
Int J Epidemiol
. 2022 Jan;
50(6):2082-2090.
PMID: 34999891
Background: There is considerable variation in mortality rates from myocardial infarction (MI) across high-income countries, some of which may be artefactual. Methods: Time trends in mortality rates from ischaemic heart...